AST is a novel anti-carcinogenic regimen against gastrointestinal cancer development with unique molecular targets (Abstract)

Joshua Ko*, Kathy K W Auyeung

*Corresponding author for this work

Research output: Contribution to journalConference articlepeer-review

Fingerprint

Dive into the research topics of 'AST is a novel anti-carcinogenic regimen against gastrointestinal cancer development with unique molecular targets (Abstract)'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science